India pharmaceutical sales company, Cipla, is setting up an incubator unit to access the latest market trends across new geographic markets.
Cipla, an India-based pharmaceutical sales company, is setting up an international incubator for start-ups. The new division will be called Cipla Ventures and will focus on start-ups specialising in biotechnology, medical devices and other healthcare segments. The size of the deals to be targeted or the full amount of capital to be invested has not been made public.
In an interview with the Economic Times of India, the company’s chief executive officer Subhanu Saxena, who joined last year…
